Tyber Medical, LLC

Tyber Medical, LLC, based in Bethlehem, US, specializes in creating innovative orthopedic implants and solutions, aimed at improving surgical outcomes in extremities, spine, and trauma procedures. Tyber Medical, LLC was founded in 2012 and is headquartered in Bethlehem, US. The company develops orthopedic implants and solutions, focusing on enhancing surgical procedures. Jeff Tyber serves as the CEO and founder.

Tyber Medical has completed a total of 3 deals, with the most recent deal taking place on January 13, 2025, when Montagu Private Equity acquired a significant stake in the company. Tyber Medical LLC specializes in the development and manufacturing of a wide array of innovative orthopedic implants and solutions, primarily focused on enhancing surgical procedures within the fields of extremities, spine, and trauma. The company's core product offerings include FDA-cleared and CE-marked implants such as the PEEK ToeGrip Hammer Toe Implant Family, the Tyber Medical Small-Fragment and Mini-Fragment Plating systems, and specialized screws like the ExRay® 30 compression screws. These products are designed to streamline surgical processes, improve patient outcomes, and cater to the specific anatomical demands of various orthopedic procedures.

Tyber Medical serves a diverse clientele, primarily consisting of orthopedic surgeons and medical device distributors across North America and Europe, providing them with state-of-the-art, ready-to-label solutions that meet rigorous quality and regulatory standards. The revenue structure at Tyber Medical is centered around business-to-business transactions with orthopedic distributors and surgical facilities. The company operates on a model that allows clients to swiftly access a portfolio of regulatory-cleared orthopedic implants, facilitating rapid market entry for its partners. Transactions typically occur through direct sales agreements or partnerships with medical device distributors, enabling clients to benefit from a diverse product range tailored to their specific needs.

This includes flagship products like the ToeGrip systems and specialized plating solutions, which are integral to their offerings. The transaction framework is designed to optimize efficiency and responsiveness in the supply chain, ensuring that customers receive high-quality products that are essential for effective surgical interventions. In January 2025, Tyber Medical will launch new products designed for orthopedic applications, aimed at expanding their offerings in the market. The company plans to grow its presence in the European and Asian markets by mid-2025, targeting orthopedic surgeons and medical distributors in these regions.

The recent investment from Montagu Private Equity will be utilized to support product development and market expansion initiatives.